Lonza, EPA Settle Over False Claims on Hospital Disinfectants

Lonza, EPA Settle Over False Claims on Hospital Disinfectants

Lonza Inc. has agreed to inspect how its products are being manufactured after it was discovered the some of the company's hospital disinfectants did not kill all the organisms they claimed to.

In March 2007, the U.S. Environmental Protection Agency accused Lonza of making false claims about their Formula 158 Lemon Disinfectant, Fresh and Clean, and REV hospital disinfectants. Each product's label said they kill the pathogen Pseudomonas aeruginosa, and REV also said it killed the pathogen Staphylococcus aureus. Both organisms can cause serious, though treatable infections.

According to the EPA, the products did not kill either of the pathogens, and under a recent settlement, Lonza will evaluate the companies that formulate its products, inspect their manufacturing plants and take other steps to ensure their products live up to their claims.

The company had previously revised the labeling on Formula 158 Lemon Disinfectant and discontinued REV.

The EPA is overseeing the company's Supplemental Environmental Project, the first of its kind nationwide. Lonza has until December 2009 to develop and fully implement the project. Only companies that are in line with regulatory, quality assurance and manufacturing compliance will be allowed to formulate Lonza's products.